Evolent Health, Inc.
Could not find a ticker for this position, may be a filing error
A healthcare services company that helps health plans, providers, and hospitals manage complex, high-cost conditions like cancer, heart disease, and musculoskeletal care. It uses its Identifi technology platform and clinical programs to help organizations move from simply billing per visit to "value-based care" that rewards better outcomes. Evolent was founded in 2011 as a joint venture between UPMC and The Advisory Board Company, based in Arlington, Virginia. Its name blends "evolution" and "benevolent," chosen to signal a kinder, transforming approach to healthcare.
3.5% Convertible Senior Notes due 2029
Granted 1.23M · Bought 55.2K · Sold 328.9K
Granted 382.8K · Bought 11.0K · Sold 45.2K
Granted 230.3K · Sold 44.7K
Granted 179.9K · Sold 42.1K
Granted 89.3K · Sold 8.9K
Granted 70.8K · Bought 11.0K
Granted 70.8K · Bought 30.0K
Granted 70.8K · Bought 10.5K
Granted 69.9K · Bought 30.0K
Granted 70.8K · Bought 2.0K
Granted 71.9K · Bought 5.4K
Granted 70.8K
Granted 29.7K
Granted 7.7K · Bought 2.7K
Granted 41.0K
Granted 64.2K
Granted 63.1K
Granted 7.7K
Granted 587.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Blackley SethChief Executive Officer, Director · 22 transactions | +5.7% | 837.0K | 1.23M | 55.2K | 328.9K |
| McCarthy Daniel JosephPRESIDENT · 24 transactions | +105% | 423.0K | 382.8K | 11.0K | 45.2K |
| Johnson John PaulChief Financial Officer · 11 transactions | +54.6% | 309.2Kas of Jul 2025 | 230.3K | — | 44.7K |
| Weinberg JonathanGeneral Counsel · 18 transactions | +63% | 244.5K | 179.9K | — | 42.1K |
| Rafferty Emily AnnChief Operating Officer · 8 transactions | +87% | 132.6Kas of Mar 2025 | 89.3K | — | 8.9K |
| Grua Peter JDirector · 4 transactions | — | 123.7K | 70.8K | 11.0K | — |
| Jelinek Richard MDirector · 5 transactions | — | 107.5K | 70.8K | 30.0K | — |
| Keck KimDirector · 4 transactions | +382.3% | 102.6K | 70.8K | 10.5K | — |
| Springstubb Brendan BDirector · 6 transactions | — | 99.9K | 69.9K | 30.0K | — |
| Barbarosh Craig A.Director · 4 transactions | +327.2% | 95.0K | 70.8K | 2.0K | — |
| Glass Russell MonroeDirector · 5 transactions | — | 83.4K | 71.9K | 5.4K | — |
| Ajayi ToyinDirector · 3 transactions | +1613.9% | 75.2K | 70.8K | — | — |
| Scott CherylDirector · 2 transactions | +36.6% | 73.5Kas of Jun 2025 | 29.7K | — | — |
| Holder DianeDirector · 2 transactions | +17.4% | 70.6Kas of Mar 2025 | 7.7K | 2.7K | — |
| Shams AammaadChief Accounting Officer · 12 transactions | +33.6% | 66.8K | 41.0K | — | — |
| Smith Jill D.Director · 2 transactions | — | 64.2K | 64.2K | — | — |
| Guertin Shawn MDirector · 2 transactions | — | 63.1K | 63.1K | — | — |
| Duffy Mary BridgetDirector · 1 transaction | -3.9% | 48.0Kas of Jun 2024 | 7.7K | — | — |
| Ramos MarioChief Financial Officer · 1 transaction | — | 0 | 587.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -311.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.